Effect of intermittent inhaled tobramycin on sputum cytokine profiles in cystic fibrosis

16Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Objectives: The aim of this study was to evaluate the anti-inflammatory properties of intermittent inhaled tobramycin. Methods: To establish this, we initiated a prospective study to measure the concentration of the three pro-inflammatory cytokines IL-8, IL-6 and TNF-α in the sputum from 20 cystic fibrosis (CF) patients (15 teenagers and 5 young adults) during cycles and off cycles. Results: A significant decrease in IL-8 (P = 0.001) and a more moderate decrease in IL-6 (P = 0.046) and TNF-α (P = 0.052) levels were observed during cycles, even if no significant decrease in the number of leucocytes was observed. Conclusions: These results associated with a decrease in the Pseudomonas aeruginosa population can contribute in part to the beneficial effect of intermittent inhaled tobramycin on pulmonary function. © The Author 2005. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved.

Author supplied keywords

Cite

CITATION STYLE

APA

Husson, M. O., Wizla-Derambure, N., Turck, D., Gosset, P., & Wallaert, B. (2005). Effect of intermittent inhaled tobramycin on sputum cytokine profiles in cystic fibrosis. Journal of Antimicrobial Chemotherapy, 56(1), 247–249. https://doi.org/10.1093/jac/dki179

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free